Adopting a holistic approach in crafting a product’s value story: utilizing HEOR and RWE throughout the product life cycle.

The most common factors for underperforming drug launches between 2012 and 2017 in the United States were limited market access, inadequate understanding of customer needs and poor product differentiation. Learn from our experts at Lumen Value & Access how HE models, and RWE can be used to overcome these challenges.

5 minute read
Download PDF

Authors

Gary Schneider
VP RWE Innovation, Lumen Value & Access
Koen Degeling
Scientific Director, Economic Modelling & Innovation Lead, Lumen Value & Access
Kathy Belk
VP HEOR, Lumen Value & Access

More Information

The Collective Intelligence Webinars leverage the global expertise of the Healthcare Consultancy Group (HCG) to provide leading professionals across pharma and biotech with thought-leadership examples of future thinking, collaboration, and communication excellence.

HCG is a global leader in medical communications, comprising 7 interconnected agencies with distinct personalities and complementary skills.

The depth of our expertise allows us to configure custom solutions to meet your scientific, regulatory, and digital needs. Discrete offices and robust processes ensure the confidentiality of your data and programs.

We give your programs the profile they deserve by building your team with you in mind.